Abstract
Vascular anomalies comprise vascular neoplasms that result from active cell proliferation and vascular malformations which are congenital defects in vascular development. The distinction between tumors and malformations was recognized by the International Society for the Study of Vascular Anomalies (ISSVA) to provide a more clinically useful classification scheme and internationally consistent nomenclature. It focuses on a systematic approach to vascular lesions that correlates predictably with clinical history, disease course, and treatment options. Vascular tumors are further classified as benign, locally aggressive (borderline), or malignant. The most common of these is infantile hemangioma. Vascular malformations, on the other hand, are named after the vessel type(s) that compose them, i.e., venous malformation, lymphatic malformation, arteriovenous malformation, and assorted variations. Fistulae represent related vascular pathologies. Orbital vascular anomalies present unique challenges owing to the compartment they occupy and the critical structures therein. These lesions can be classified independent of tissue type, based on flow radiographic and clinical flow characteristics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69(3):412–22.
Haggstrom AN, Drolet BA, Baselga E, et al. Hemangioma Investigator Group. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150(3):291–4.
North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31(1):11–22.
Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18(6):894–900.
Fay A, Santiago YM, Waner M. Infantile hemangiomas and other vascular neoplasms. In: Fay A, Dolman P. Diseases and disorders of the orbit and ocular adnexa. Elsevier. 2018.
Margileth AM, Museles M. Cutaneous hemangiomas in children. Diagnosis and conservative management. JAMA. 1965;194(5):523–6.
Zallmann M, Leventer RJ, Mackay MT, et al. Screening for Sturge-Weber syndrome: a state-of-the-art review. Pediatr Dermatol. 2018;35(1):30–42.
Robb RM. Refractive errors associated with hemangiomas of the eyelids and orbit in infancy. Am J Ophthalmol. 1977;83(1):52–8.
Schwartz SR, Blei F, Ceisler E, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS. 2006;10(3):262–8.
Haik BG, Karcioglu ZA, Gordon RA, et al. Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmol. 1994;38(5):399–426.
Lowe LH, Marchant TC, Rivard DC, et al. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol. 2012;47(2):106–17.
Waner M, Suen JY. A classification of congenital vascular lesions. . In: Waner M, Suen JY, eds. Hemangiomas and vascular malformations of the head and neck New York: J: Wiley-Liss, 1999.
Pratt AG. Birthmarks in infants. AMA Arch Derm Syphilol. 1953;67(3):302–5.
Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51.
Fay A, Nguyen J, Waner M. Conceptual approach to the management of infantile hemangiomas. J Pediatr. 2010;157(6):881–8 e1-5.
Dieterich-Miller CA, Cohen BA, Liggett J. Behavioral adjustment and self-concept of young children with hemangiomas. Pediatr Dermatol. 1992;9(3):241–5.
Ruttum MS, Abrams GW, Harris GJ, et al. Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus. 1993;30(1):4–7.
Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg. 1986;17(4):229–31.
Egbert JE, Schwartz GS, Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol. 1996;121(6):638–42.
Droste PJ, Ellis FD, Sondhi N, et al. Linear subcutaneous fat atrophy after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol. 1988;105(1):65–9.
Sutula FC, Glover AT. Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma. Ophthalmic Surg. 1987;18(2):103–5.
Sagi L, Zvulunov A, Lapidoth M, et al. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Dermatology. 2014;228(2):136–44.
Lou Y, Peng WJ, Cao Y, et al. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78(1):44–57.
Bauman NM, McCarter RJ, Guzzetta PC, et al. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014;140(4):323–30.
Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996;128(3):329–35.
Ooi KG, Wenderoth JD, Francis IC, et al. Selective embolization and resection of a large noninvoluting congenital hemangioma of the lower eyelid. Ophthalmic Plast Reconstr Surg. 2009;25(2):111–4.
Sturgis EM, Potter BO. Sarcomas of the head and neck region. Curr Opin Oncol. 2003;15(3):239–52.
Demirci H, Christanson MD. Eyelid angiosarcoma: a case report and review of the literature. Middle East Afr J Ophthalmol. 2013;20(3):259–62.
Young RJ, Brown NJ, Reed MW, et al. Angiosarcoma. Lancet Oncol. 2010;11(10):983–91.
Morgan MB, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50(6):867–74.
Harris GJ. Orbital vascular malformations: a consensus statement on terminology and its clinical implications. Orbital society. Am J Ophthalmol. 1999;127(4):453–5.
Wiegand S, Eivazi B, Bloch LM, et al. Lymphatic malformations of the orbit. Clin Exp Otorhinolaryngol. 2013;6(1):30–5.
Greene AK, Burrows PE, Smith L, et al. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005;115(1):22–30.
Hall N, Ade-Ajayi N, Brewis C, et al. Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery. 2003;133(3):238–42.
Yue H, Qian J, Elner VM, et al. Treatment of orbital vascular malformations with intralesional injection of pingyangmycin. Br J Ophthalmol. 2013;97(6):739–45.
Gandhi NG, Lin LK, O’Hara M. Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmol. 2013;131(9):1228–30.
Swetman GL, Berk DR, Vasanawala SS, et al. Sildenafil for severe lymphatic malformations. N Engl J Med. 2012;366(4):384–6.
Ernemann U, Westendorff C, Troitzsch D, et al. Navigation-assisted sclerotherapy of orbital venolymphatic malformation: a new guidance technique for percutaneous treatment of low-flow vascular malformations. AJNR Am J Neuroradiol. 2004;25(10):1792–5.
Goldberg RA, Garcia GH, Duckwiler GR. Combined embolization and surgical treatment of arteriovenous malformation of the orbit. Am J Ophthalmol. 1993;116(1):17–25.
Werner JA, Dunne AA, Folz BJ, et al. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol. 2001;258(3):141–9.
Osaki T, Fay A, Waner M. Vascular malformations. In: Fay A, Dolman P, editors. Diseases and disorders of the orbit and ocular adnexa. Edinburgh: Elsevier; 2018.
Multimodal management of arteriovenous malformations of the basal ganglia and thalamus: factors affecting obliteration and outcome. J Neurosurg. 2018:1–10.
Chelliah MP, Do HM, Zinn Z, et al. Management of complex arteriovenous malformations using a novel combination therapeutic algorithm. JAMA Dermatol. 2018;154(11):1316–9.
Calandriello L, Grimaldi G, Petrone G, et al. Cavernous venous malformation (cavernous hemangioma) of the orbit: current concepts and a review of the literature. Surv Ophthalmol. 2017;62(4):393–403.
Osaki TH, Jakobiec FA, Mendoza PR, et al. Immunohistochemical investigations of orbital infantile hemangiomas and adult encapsulated cavernous venous lesions (malformation versus hemangioma). Ophthalmic Plast Reconstr Surg. 2013;29(3):183–95.
Bruder E, Perez-Atayde AR, Jundt G, et al. Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification. Virchows Arch. 2009;454(2):161–79.
McNab AA, Wright JE. Cavernous haemangiomas of the orbit. Aust N Z J Ophthalmol. 1989;17(4):337–45.
Xian J, Zhang Z, Wang Z, et al. Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit. Eur Radiol. 2010;20(9):2221–8.
Kim JW, Im YS, Nam DH, et al. Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients. J Korean Neurosurg Soc. 2008;44(2):67–71.
Goh ASC, Kim YD, Woo KI, Lee JI. Benign orbital apex tumors treated with multisession gamma knife radiosurgery. Ophthalmology. 2013;120(3):635–41.
Young SM, Kim KH, Kim Y-D, et al. Orbital apex venous cavernous malformation with optic neuropathy – treatment with multisession Gamma knife radiosurgery. Br J Ophthalmol. 2019;. epub ahead of print
Chhabra N, Wu AW, Fay A, et al. Endoscopic resection of orbital hemangiomas. Int Forum Allergy Rhinol. 2014;4(3):251–5.
Kiratli H, Bulur B, Bilgic S. Transconjunctival approach for retrobulbar intraconal orbital cavernous hemangiomas. Orbital surgeon’s perspective. Surg Neurol. 2005;64(1):71–4.
Brusati R, Goisis M, Biglioli F, et al. Surgical approaches to cavernous haemangiomas of the orbit. Br J Oral Maxillofac Surg. 2007;45(6):457–62.
Croxatto JO, Font RL. Hemangiopericytoma of the orbit: a clinicopathologic study of 30 cases. Hum Pathol. 1982;13:210218.
Fletcher CDM, Bridge JA, Hogendoorn P, et al. WHO classification of tumours. In: WHO classification of tumours of soft tissue and bone, vol. 5. 4th ed: IARC; Geneva, Switzerland, 2013. http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4005#
Karcioglu ZA, Nasr AM, Haik BG. Orbital hemangiopericytoma: clinical and morphologic features. Am J Ophthalmol. 1997;124(5):661–72.
Bernardini FP, de Conciliis C, Schneider S, et al. Solitary fibrous tumor of the orbit: is it rare? Report of a case series and review of the literature. Ophthalmology. 2003;110(7):1442–8.
Girnita L, Sahlin S, Orrego A, et al. Malignant solitary fibrous tumour of the orbit. Acta Ophthalmol. 2009;87(4):464–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Santiago, Y.M., Fay, A. (2019). Orbital Vascular Anomalies. In: Hwang, C.J., Patel, B.C., Singh, A.D. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-13558-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-13558-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13557-7
Online ISBN: 978-3-030-13558-4
eBook Packages: MedicineMedicine (R0)